<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Amgen - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/amgen/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/amgen/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Tue, 26 Nov 2019 10:46:45 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>Amgen - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/amgen/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Malattie cardiovascolari ed osteoporosi: un legame a doppio filo</title>
		<link>https://www.newpharmaitaly.it/malattie-cardiovascolari-ed-osteoporosi-un-legame-a-doppio-filo/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Tue, 26 Nov 2019 10:46:45 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[#ProtectUrLife]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[malattie cardiovascolari]]></category>
		<category><![CDATA[Ministero della Salute]]></category>
		<category><![CDATA[osteoporosi]]></category>
		<guid isPermaLink="false">https://www.newpharmaitaly.it/?p=3904</guid>

					<description><![CDATA[<p>Torna la campagna #ProtectUrLife per sensibilizzare e informare la popolazione over 60 sulla prevenzione di malattie cardiovascolari ed osteoporosi In Italia il 14,7% degli over 60 presenta un rischio alto o molto alto di mortalità causata da un evento cardiovascolare, rispetto al 10,3% della media europea. La percentuale sale al 77,2%, se consideriamo un rischio [&#8230;]</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/malattie-cardiovascolari-ed-osteoporosi-un-legame-a-doppio-filo/">Malattie cardiovascolari ed osteoporosi: un legame a doppio filo</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Luigi Uccella nominato Human Resources Director in Grünenthal Italia</title>
		<link>https://www.newpharmaitaly.it/luigi-uccella-nominato-human-resources-director-in-grunenthal-italia/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Thu, 12 Sep 2019 10:10:16 +0000</pubDate>
				<category><![CDATA[Protagonisti]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[Aldo Sterpone]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[Grünenthal Italia]]></category>
		<category><![CDATA[Luigi Uccella]]></category>
		<guid isPermaLink="false">https://www.newpharmaitaly.it/?p=3799</guid>

					<description><![CDATA[<p>Nuove nomine annunciate in Grünenthal Italia, Luigi Uccella entrerà nel team in qualità di HR Director per la filiale italiana Napoletano, classe 1976, ha maturato esperienze in ambito pharma in Abbott e dal 2008 in Amgen; ora assume la direzione della divisione HR ed entra nel Management team della filiale di Grünenthal Italia. Aldo Sterpone, Presidente [&#8230;]</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/luigi-uccella-nominato-human-resources-director-in-grunenthal-italia/">Luigi Uccella nominato Human Resources Director in Grünenthal Italia</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
